2003
DOI: 10.1016/s1043-4666(03)00179-0
|View full text |Cite
|
Sign up to set email alerts
|

SP500263, a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSF

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2004
2004
2010
2010

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 62 publications
0
13
0
Order By: Relevance
“…Previous osteoclast assays for measurement of compound activity were either done with non-human cells (mouse, rat, rabbit) [12-14], or, if they used human cells, were done with a human monocytic cell line in co-cultures with osteoblastic cells [15], or used human bone marrow-derived osteoclasts [4], or human tumor osteoclastoma-derived cells [9]. Although useful, these methods do not use active primary human osteoclasts.…”
Section: Discussionmentioning
confidence: 99%
“…Previous osteoclast assays for measurement of compound activity were either done with non-human cells (mouse, rat, rabbit) [12-14], or, if they used human cells, were done with a human monocytic cell line in co-cultures with osteoblastic cells [15], or used human bone marrow-derived osteoclasts [4], or human tumor osteoclastoma-derived cells [9]. Although useful, these methods do not use active primary human osteoclasts.…”
Section: Discussionmentioning
confidence: 99%
“…Neutralising antibodies to IL-6 decrease the formation of osteoclast-like cells 37. Furthermore, increased circulating IL-6 levels in paediatric IBD patients are negatively correlated with BMD38 and IL-6 gene polymorphisms influence BMD in patients with Crohn’s disease (fig 1B).…”
Section: Inflammation and Bone Loss: Cell Types And Mediators Involvementioning
confidence: 98%
“…Two major ways to overcome this problem have been described in literature. The first is based on the use of different human-derived cellular models and is widely used today [179,180], whereas the second is based on the use of ovariectomized cynomolgus monkeys. The latter model is based on the findings that human and monkey cathepsin K sequences are identical and that the expressed proteins exhibit indistinguishable enzymatic properties, and was introduced by the researchers from GlaxoSmithKline [181].…”
Section: Development Of Cathepsin K Inhibitors: a New Approach In Ostmentioning
confidence: 99%